Literature DB >> 147885

A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man.

E G Engleman, H O McDevitt.   

Abstract

The mixed lymphocyte reaction (MLR) is the proliferative response of one individual's lymphocytes cultured in the presence of another individual's lymphocytes. In man, the MLR is elicited by cell surface antigens coded for by the HLA-D gene locus. This locus is among a cluster of genes which are located on the sixth chromosome and which include genes coding for the major histocompatibility antigens HLA-A, B, and C as well as HLA-D. If the stimulator cell possesses D locus antigens not present in the responder, the lymphocytes of the latter will undergo blast transformation resulting in DNA synthesis which can be measured. A vigorous response in the MLR to allogeneic cells is the rule among healthy individuals. We describe studies of a 23-yr-old man whose lymphocytes respond normally to mitogens and soluble antigens but fail to respond to allogeneic cells in the MLR. His medical history is unremarkable except that he received thymic irradiation as an infant. HLA typing revealed that he is homozygous for HLA-A2, B12, and Cw5 as well as for the D locus antigen Dw4. When his lymphocytes were added to the responder lymphocytes of other persons homozygous for the same HLA antigens, their responses to allogeneic cells but not mitogens were suppressed by 50-95%. Their responses to a soluble antigen, tetanus toxoid, were suppressed to a lesser degree. These inhibitory effects were mediated by a relatively radioresistant thymus-derived (T) lymphocyte. Further studies of the requirements for MLR suppression revealed that only persons heterozygous or homozygous for the Dw4 antigen were inhibited by the suppressor T cell. This effect was not altered by differences in the HLA-A, B, or C antigens between the suppressor and responder. It is concluded that genes in or near the HLA-D locus code not only for antigens (primarily on bone marrow-derived (B) cells), that elicit the MLR, but also for structures on T cells, or possibly macrophages, which are recognized by MLR suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 147885      PMCID: PMC372598          DOI: 10.1172/JCI108997

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  The association between the HLA system and disease.

Authors:  A McMichael; H McDevitt
Journal:  Prog Med Genet       Date:  1977

2.  Thyroid cancer in childhood and adolescence; a report on 28 cases.

Authors:  B J DUFFY; P J FITZGERALD
Journal:  Cancer       Date:  1950-11       Impact factor: 6.860

3.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

4.  Identification and quantitation of thymus-derived lymphocytes in human peripheral blood.

Authors:  A M Bobrove; S Strober; L A Herzenberg; J D DePamphilis
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

Review 5.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

6.  Suppressor thymus-derived lymphocytes in fungal infection.

Authors:  J D Stobo; S Paul; R E Van Scoy; P E Hermans
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

7.  Increased sensitivity of the rosette-forming reaction of human T lymphocytes with sheep erythrocytes afforded by papain treatment of the sheep cells.

Authors:  A B Wilson; D G Haegert; R R Coombs
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

8.  Alteration of T cell function in healthy persons with a history of thymic x-irradiation.

Authors:  C H Rieger; S C Kraft; R M Rothberg
Journal:  J Allergy Clin Immunol       Date:  1975-10       Impact factor: 10.793

9.  Hodgkin's disease. An immunodepleting and immunosuppressive disorder.

Authors:  J J Twomey; A H Laughter; S Farrow; C C Douglass
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Regulatory mechanisms in cell-mediated immune responses. III. I-region control of suppressor cell interaction with responder cells in mixed lymphocyte reactions.

Authors:  S S Rich; R R Rich
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

View more
  13 in total

Review 1.  The use of concanavalin A to study the immunoregulation of human T cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

Review 2.  Autoimmunity and HLA.

Authors:  C B Carpenter
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

3.  Regulation of the human allogeneic proliferative response in vitro.

Authors:  E Carosella; A Bensussan; V Lepage; M Sasportes
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Regulation of the human allogenic proliferative response in vitro. II. Production of soluble suppressor factors by suppressor T cells and evidence in favor of "acceptor" cells for suppression among unprimed lymphocytes.

Authors:  M Sasportes; E Carosella; A Bensussan; C Mihaesco; J Dausset
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

Review 5.  [The significance of Fc-IgG and Fc-IgM receptors on human T-lymphocytes (author's transl)].

Authors:  W J Pichler
Journal:  Klin Wochenschr       Date:  1981-02-02

6.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.

Authors:  E G Engleman; C J Benike; R T Hoppe; H S Kaplan; F R Berberich
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

8.  Heterogeneity of b lymphocyte differentiation in severe combined immunodeficiency disease.

Authors:  S G Pahwa; R N Pahwa; R A Good
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

9.  Functional characteristics of human T-cell subpopulations distinguished by a monoclonal antibody.

Authors:  E G Engleman; C Benike; B Osborne; R Goldsby
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  Allogeneic suppressive effects of pregnancy sera on monocytes of responding cells in human mixed lymphocyte reactions.

Authors:  M Nieda; T Juji; S Imao
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.